Curcumin induces apoptosis and autophagy inhuman renal cell carcinoma cells via Akt/mTOR suppression

References

• Fang Z, Tang Y, Fang J, et al. Simvastatin inhibits renal cancer cell growth and metastasis via AKT/mTOR, ERK and JAK2/STAT3 pathway. PLoS One. 2013;8:e62823.
   PubMed Web of Science ®Google Scholar
• Nerli RB, Patil SM, Pathade A, et al. Metastases of renal cell carcinoma to the contralateral adrenal gland managed by laparoscopic adrenalectomy. Indian J Surg Oncol. 2017;8:326–330.
   PubMed Web of Science ®Google Scholar
• Padala SA, Barsouk A, Thandra KC, et al. Epidemiology of renal cell carcinoma. World J Oncol. 2020;11:79–87.
   PubMedGoogle Scholar
• Belldegrun AS, Klatte T, Shuch B, et al. Cancer-specific survival outcomes among patients treated during the cytokine era of kidney cancer (1989-2005): a benchmark for emerging targeted cancer therapies. Cancer. 2008;113:2457–2463.
   PubMed Web of Science ®Google Scholar
• Atzpodien J, Küchler T, Wandert T, et al. Rapid deterioration in quality of life during interleukin-2- and alpha-interferon-based home therapy of renal cell carcinoma is associated with a good outcome. Br J Cancer. 2003;89:50–54.
   PubMed Web of Science ®Google Scholar
• Stefflova K, Chen J, Zheng G. Killer beacons for combined cancer imaging and therapy. Curr Med Chem. 2007;14:2110–2125.
   PubMed Web of Science ®Google Scholar
• Lin CL, Cheng YS, Li HH, et al. Amyloid-β suppresses AMP-activated protein kinase (AMPK) signaling and contributes to α-synuclein-induced cytotoxicity. Exp Neurol. 2016;275(Pt 1):84–98.
   PubMedGoogle Scholar
• Li Y, Su J, Sun W, et al. AMP-activated protein kinase stimulates osteoblast differentiation and mineralization through autophagy induction. Int J Mol Med. 2018;41:2535–2544.
   PubMed Web of Science ®Google Scholar
• Kim J, Jung KH, Ryu HW, et al. Apoptotic effects of xanthium strumarium via PI3K/AKT/mTOR pathway in hepatocellular carcinoma. Evid Based Complement Alternat Med. 2019;2019:2176701.
   PubMed Web of Science ®Google Scholar
• Huang Y, Wu S, Zhang Y, et al. Antitumor effect of triptolide in T-cell lymphoblastic lymphoma by inhibiting cell viability, invasion, and epithelial-mesenchymal transition via regulating the PI3K/AKT/mTOR pathway. Onco Targets Ther. 2018;11:769–779.
   PubMed Web of Science ®Google Scholar
• Ma Z, Sheng N, Liu X, et al. Knockout of Stat5 in T cells ameliorates high cholesterol and high fat diet-induced hypercholesterolemia by influencing cholesterol metabolism in the liver. Cell Mol Immunol. 2020. DOI:10.1038/s41423-020-0389-8
   Web of Science ®Google Scholar
• Yamauchi Y, Furukawa K, Hamamura K, et al. Positive feedback loop between PI3K-Akt-mTORC1 signaling and the lipogenic pathway boosts Akt signaling: induction of the lipogenic pathway by a melanoma antigen. Cancer Res. 2011;71:4989–4997.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Jiang X, Peng K, et al. Discovery and evaluation of novel anti-inflammatory derivatives of natural bioactive curcumin. Drug Des Devel Ther. 2014;8:2161–2171.
   PubMed Web of Science ®Google Scholar
• Salem M, Rohani S, Gillies ER. Curcumin, a promising anti-cancer therapeutic: a review of its chemical properties, bioactivity and approaches to cancer cell delivery. RSC Adv. 2014;4:10815–10829.
   Web of Science ®Google Scholar
• Basile V, Ferrari E, Lazzari S, et al. Curcumin derivatives: molecular basis of their anti-cancer activity. Biochem Pharmacol. 2009;78:1305–1315.
   PubMed Web of Science ®Google Scholar
• Chen YC, Shie MY, Wu YA, et al. Anti-inflammation performance of curcumin-loaded mesoporous calcium silicate cement. J Formos Med Assoc. 2017;116:679–688.
   PubMed Web of Science ®Google Scholar
• Sharma RA, Gescher AJ, Steward WP. Curcumin: the story so far. Eur J Cancer. 2005;41:1955–1968.
   PubMed Web of Science ®Google Scholar
• Penmetsa BS. Role of NF-KB in changing the expression of COX-2, P53 and Caspase-3, in PC-3 cells treated with curcumin. Lowell: University of Massachusetts; 2012.
   Google Scholar
• Song S-C, Mai Y-L, Shi -H-H, et al. High anti-cancer activity, low animal toxicity, and structure activity relationships of curcumin analogs. Lett Drug Des Discovery. 2020;17:1439–1455.
   Web of Science ®Google Scholar
• Ye M, Zhang J, Zhang J, et al. Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer. Cancer Lett. 2015;357:196–205.
   PubMed Web of Science ®Google Scholar
• Jain SK, Rains J, Croad J, et al. Curcumin supplementation lowers TNF-alpha, IL-6, IL-8, and MCP-1 secretion in high glucose-treated cultured monocytes and blood levels of TNF-alpha, IL-6, MCP-1, glucose, and glycosylated hemoglobin in diabetic rats. Antioxid Redox Signal. 2009;11:241–249.
   PubMed Web of Science ®Google Scholar
• Hu A, Huang JJ, Jin XJ, et al. Curcumin suppresses invasiveness and vasculogenic mimicry of squamous cell carcinoma of the larynx through the inhibition of JAK-2/STAT-3 signaling pathway. Am J Cancer Res. 2015;5:278–288.
   PubMed Web of Science ®Google Scholar
• Fulzele SV, Chatterjee A, Shaik MS, et al. Inhalation delivery and anti-tumor activity of celecoxib in human orthotopic non-small cell lung cancer xenograft model. Pharm Res. 2006;23:2094–2106.
   PubMed Web of Science ®Google Scholar
• Markowitsch SD, Schupp P, Lauckner J, et al. Artesunate inhibits growth of sunitinib-resistant renal cell carcinoma cells through cell cycle arrest and induction of ferroptosis. Cancers (Basel). 2020;12:3150.
   PubMed Web of Science ®Google Scholar
• Reuter S, Eifes S, Dicato M, et al. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells. Biochem Pharmacol. 2008;76:1340–1351.
   PubMed Web of Science ®Google Scholar
• Xu B, Peng Y-J, Zhu W-J. Curcumin inhibits viability of clear cell renal cell carcinoma by down-regulating ADAMTS18 gene methylation though NF-κ B and AKT signaling pathway. Chin J Integr Med. 2021. DOI:10.1007/s11655-021-3445-z
   Web of Science ®Google Scholar
• Zhang H, Xu W, Li B, et al. Curcumin promotes cell cycle arrest and inhibits survival of human renal cancer cells by negative modulation of the PI3K/AKT signaling pathway. Cell Biochem Biophys. 2015;73:681–686.
   PubMed Web of Science ®Google Scholar
• Ojha R, Bhattacharyya S, Singh SK. Autophagy in cancer stem cells: a potential link between chemoresistance, recurrence, and metastasis. Biores Open Access. 2015;4:97–108.
   PubMed Web of Science ®Google Scholar
• White E. The role for autophagy in cancer. J Clin Invest. 2015;125:42–46.
   PubMed Web of Science ®Google Scholar
• Moretti L, Yang ES, Kim KW, et al. Autophagy signaling in cancer and its potential as novel target to improve anticancer therapy. Drug Resist Updat. 2007;10:135–143.
   PubMed Web of Science ®Google Scholar
• Fu LL, Cheng Y, Liu B. Beclin-1: autophagic regulator and therapeutic target in cancer. Int J Biochem Cell Biol. 2013;45:921–924.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang J, Xu J, et al. Curcumin targets the TFEB-lysosome pathway for induction of autophagy. Oncotarget. 2016;7:75659–75671.
   PubMed Web of Science ®Google Scholar
• Shakeri A, Cicero AFG, Panahi Y, et al. Curcumin: a naturally occurring autophagy modulator. J Cell Physiol. 2019;234:5643–5654.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Bu S. Curcumin induces autophagy, apoptosis, and cell cycle arrest in human pancreatic cancer cells. Evid Based Complement Alternat Med. 2017;2017:5787218.
   PubMed Web of Science ®Google Scholar